CIK 0001789972
- Non-accelerated filer
- Smaller reporting company
Cullinan Therapeutics, Inc.
Sign in to watch- Ticker
- CGEM
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 813879991
- Phone
- +1 617-410-4650
- Business address
- ONE MAIN STREET, SUITE 1350, CAMBRIDGE, MA, 02142
- Former names
- Cullinan Oncology, Inc., Cullinan Management, Inc., Cullinan Oncology, LLC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $222,000
- in 2 filings, $222K under 10b5-1 plans
Net −$222,000. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-06-10 | Ebeling Thomas Director | Exercise or conversion | +18,450 | $13.00 | $240K | 186,653 |
| 2024-06-10 | Ebeling Thomas Director | Exercise or conversion · Stock Option (Right to Buy) | −18,450 | 0 | ||
| 2024-05-23 | Ebeling Thomas Director | Grant or award | +84,224 | $4.30 | $362K | 151,728 |
| 2024-05-23 | Ebeling Thomas Director | Grant or award | +16,475 | $12.73 | $210K | 168,203 |
| 2024-05-23 | Ebeling Thomas Director | Exercise or conversion · Stock Option (Right to Buy) | −84,224 | 0 | ||
| 2024-05-23 | Ebeling Thomas Director | Exercise or conversion · Stock Option (Right to Buy) | −16,475 | 0 | ||
| 2023-06-08 | Ebeling Thomas Director | Grant or award · Stock Option (Right to Buy) | +18,450 | 18,450 | ||
| 2022-06-22 | Ebeling Thomas Director | Grant or award · Stock Option (Right to Buy) | +16,475 | 16,475 | ||
| 2021-09-16 | Ebeling Thomas Director | Grant or award · Stock Option (Right to Buy) | +7,800 | 7,800 |
Page 1 of 1 · 9 trades